Overview

A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in Men

Status:
Completed

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The influence of severely diminished liver function on the metabolism, safety, and tolerability of a single oral dose of enzalutamide in a group of 8 men. The results are compared to the data gained from 8 age- and BMI-matched men with normal liver function.

Phase:

Phase 1

Details

Lead Sponsor:

Astellas Pharma Europe B.V.

Collaborator:

Medivation, Inc.